Our March Madness experts analyze the Final Four matchup between No. 2 UConn vs No. 3 Illinois in the 2026 NCAA Tournament on ...
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis-free survival than leuprolide alone among patients with biochemically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results